Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube
SUBSCRIBE

Infectious Disease CE Activities

RMEI DECISION SUPPORT AIDS

View Details

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.
  • Infectious Disease, Pulmonology
  • Decision Support Aid
DOWNLOAD
View Details

Diagnostic and Susceptibility Testing for Nontuberculous Mycobacterial Lung Diseases

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is a challenging infection that is becoming increasingly prevalent and continues to be a growing concern.
  • Infectious Disease, Pulmonology
  • Decision Support Aid
DOWNLOAD
View Details

Considering Therapies for Influenza Treatment and Post-Exposure in Children

This Decision Support Aid serves as a quick reference to help clinicians apply information to their daily practice and care of patients.
  • Infectious Disease
  • Decision Support Aid
DOWNLOAD

LATEST INFECTIOUS DISEASE ARTICLES

RSS feed: Latest Infectious Disease Articles Latest Infectious Disease Articles
  • Human Adenovirus B3–Induced Immune Thrombocytopenia and Thrombosis September 17, 2026
    Virus-induced immune thrombocytopenia and thrombosis after HAdV-B3 infection supports a shared platelet factor 4–targeted immune mechanism linking natural adenovirus infection and adenoviral vector–associated disease.
    Christian Irsara, Habib Benainouna, Jing Jing Wang, Andrea Griesmacher, Christoph Winkler, Lorin Loacker, Markus Anliker, Xiaoyan Wang, Alex Moser, Thomas Müller, Werner Streif, Andreas Greinacher, Thomas Thiele, Wibke Bayer, Linda Schönborn
  • Honoring the Legacy of the HIV Epidemic September 17, 2026
    Progress against the U.S. HIV epidemic is stalling, owing in part to government attacks and fear. But clinicians, patients, and activists can learn from the epidemic’s early heroes and find ways to advance.
    Ofole Mgbako
  • Short or Long Antibiotic Regimens in Orthopedics September 16, 2026
    In a randomized trial involving adults who received local antibiotics during surgery for orthopedic infection, a short duration of systemic antibiotics was noninferior to a long duration regarding treatment failure at 12 months.
    Martin McNally, Maria Dudareva, Michelle Kümin, Werner Vach, Claire L. Scarborough, Matthew J. Cichero, Ricardo Sousa, Jamie Ferguson, David A. Stubbs, Bridget L. Atkins, Alex J. Ramsden, Bernadette C. Young, Andre D. Carvalho, Adrian R. Kendal, Abtin Alvand, Antony J.R. Palmer, Con L. Loizou, Ben Kendrick, Adrian H. Taylor, Amirul Islam, Michael J. Riste, Anand Pillai, Sunil K. Sharma, Jonathan Folb, Neal Jacobs, Simon C. Ellis, Aaron B.Y. Ng, Daniel Perez-Prieto, Irene K. Sigmund, Reinhard Windhager, Alexis D. Iliadis, Andrew J.F. Bing, Henry Wynn Jones, John Williams, Ben J. Ollivere, Volker Alt, Simon Warren, Neil E. Jenkins, Andreas Leithner, Harriet C. Hughes, Steve A. Jones, O. Martin Williams, Matthew Scarborough

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
  • Allergy & Immunology
  • 2021
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
  • Gastroenterology
  • 2021

Previously Published CE Activities